York County-based Unilife Corp. continued its recent roller-coaster journey with news of another class-action lawsuit followed closely by yet another business deal.
The lawsuit, filed by Pomerantz Grossman Hufford Dahlstrom & Gross LLP in U.S. District Court, Middle District of Pennsylvania, essentially piggybacks on the federal suit filed in August by Unilife's former vice president of integrated supply chain, who accused the company of misleading investors and failing to comply with FDA regulations.
Unilife CEO Alan Shortall has previously said in reference to the interconnected litigation that the company is in full compliance and will prevail.
The new agreement is to supply Novartis with clinical products from one of Unilife's injectable drug delivery systems for use with a targeted early-stage pipeline drug. Unilife said that it granted Novartis an option for exclusivity and that additional terms are to remain confidential at this time.